Federal Judge Approves Purdue Pharma Opioid Settlement, Sackler Family to Contribute $7 Billion

A federal judge approved Purdue Pharma's opioid settlement, requiring the Sackler family to contribute up to $7 billion over 15 years, with funds primarily aiding governments and victims of the crisis.

L 50%
C 50%

Overview

A summary of the key points of this story verified across multiple sources.

1.

A federal bankruptcy court judge formally approved Purdue Pharma's comprehensive plan to settle numerous lawsuits related to the opioid crisis, including the company's owners, the Sackler family.

2.

The Sackler family, owners of Purdue Pharma, is mandated to contribute up to $7 billion over a 15-year period as a crucial component of the extensive opioid settlement agreement.

3.

A significant portion of the approved settlement funds is designated for government entities, aiming to combat the ongoing opioid crisis responsible for 900,000 U.S. deaths since 1999.

4.

Purdue Pharma will be dissolved and replaced by a new entity, Knoa Pharma, which will operate under the control of a state-appointed board with a dedicated public-interest mission.

5.

The settlement provides payments to state and local governments and individual victims, while also allowing those who do not opt into the deal to pursue separate lawsuits against Sackler family members.

Written using shared reports from
4 sources
.
Report issue

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Center-leaning sources cover this story neutrally, focusing on the factual details of the Purdue Pharma settlement approval. They present the judge's decision, the Sackler family's contribution, and the deal's purpose without loaded language or overt editorial bias. The reporting prioritizes clarity and attribution, ensuring readers receive an objective account of the legal development.

Sources (4)

Compare how different news outlets are covering this story.

FAQ

Dig deeper on this story with frequently asked questions.

The Sackler family is required to contribute up to $7 billion over 15 years as part of the opioid settlement.

A significant portion of the settlement funds is designated for government entities to combat the opioid crisis and provide payments to state and local governments and individual victims.

Purdue Pharma will be dissolved and replaced by a new entity called Knoa Pharma, which will be controlled by a state-appointed board with a public-interest mission.

Yes, individuals or entities that do not opt into the settlement are allowed to pursue separate lawsuits against Sackler family members.

Local governments had deadlines in 2025, such as September 30 for joining the Purdue settlement and October 8 for secondary opioid manufacturer settlements, to participate and receive settlement funds.

History

See how this story has evolved over time.

This story does not have any previous versions.